Amelia Grace Stapleton Van Doren, Hemali Shah, Ruthia Chen, Dia Shah, Samantha King, Lucie Joerg, Ekaterina Sazon, Francisco Alicandri, Aasim Jaffri, Aimi Toyama Rothrock, Lindy Davis
{"title":"Variability in synoptic reporting and inclusion of essential histopathologic elements in cutaneous melanoma biopsy pathology reports.","authors":"Amelia Grace Stapleton Van Doren, Hemali Shah, Ruthia Chen, Dia Shah, Samantha King, Lucie Joerg, Ekaterina Sazon, Francisco Alicandri, Aasim Jaffri, Aimi Toyama Rothrock, Lindy Davis","doi":"10.1097/CMR.0000000000001106","DOIUrl":null,"url":null,"abstract":"<p><p>Complete, accurate melanoma pathology reports are essential for effective communication between pathologists and treating physicians. The College of American Pathologists (CAP) recommends synoptic reporting for melanoma biopsy pathology reports, while an American Academy of Dermatology (AAD) work group recommended inclusion of essential elements. We aimed to assess completeness of biopsy pathology reports according to the CAP guidelines and AAD recommendations. Biopsy reports of patients referred for invasive melanoma treatment to our academic center from 2017 to 2022 were retrospectively reviewed. Sixty-two percent of reports included all core elements outlined within the CAP guidelines, while 54% of reports included all AAD recommendations. Frequently omitted elements included margin status as well as neurotropism. Breslow depth and ulceration were included in 99% of reports. Report completeness was significantly associated with laboratory type, with the highest rates observed at academic centers and the lowest at third-party laboratories. Variability in melanoma biopsy pathology reporting remains common. Incomplete documentation, including deep margin status, may introduce uncertainty in pathologic T stage interpretation from a surgical management perspective. Wider adoption of standardized biopsy templates may improve reporting consistency, while increased awareness of biopsy report interpretation and application may reduce ambiguity and improve communication between pathologists and clinicians.</p>","PeriodicalId":18550,"journal":{"name":"Melanoma Research","volume":" ","pages":"307-313"},"PeriodicalIF":1.8000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CMR.0000000000001106","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Complete, accurate melanoma pathology reports are essential for effective communication between pathologists and treating physicians. The College of American Pathologists (CAP) recommends synoptic reporting for melanoma biopsy pathology reports, while an American Academy of Dermatology (AAD) work group recommended inclusion of essential elements. We aimed to assess completeness of biopsy pathology reports according to the CAP guidelines and AAD recommendations. Biopsy reports of patients referred for invasive melanoma treatment to our academic center from 2017 to 2022 were retrospectively reviewed. Sixty-two percent of reports included all core elements outlined within the CAP guidelines, while 54% of reports included all AAD recommendations. Frequently omitted elements included margin status as well as neurotropism. Breslow depth and ulceration were included in 99% of reports. Report completeness was significantly associated with laboratory type, with the highest rates observed at academic centers and the lowest at third-party laboratories. Variability in melanoma biopsy pathology reporting remains common. Incomplete documentation, including deep margin status, may introduce uncertainty in pathologic T stage interpretation from a surgical management perspective. Wider adoption of standardized biopsy templates may improve reporting consistency, while increased awareness of biopsy report interpretation and application may reduce ambiguity and improve communication between pathologists and clinicians.
期刊介绍:
Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.